The Dioxin receptor modulates Caveolin-1 mobilization during directional migration: Role of cholesterol

Cell Communication and Signaling

Volumn 12, Issue 1, 2014, Pages

  Rey Barroso, Javier ^a   Alvarez Barrientos, Alberto ^a   Rico Leo, Eva ^a   Contador Troca, María ^a   Carvajal Gonzalez, José M ^b   Echarri, Asier ^c   Del Pozo, Miguel A ^c   Fernandez Salguero, Pedro M ^a  

^a UNIVERSITY OF EXTREMADURA   (Spain)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

Author keywords

Caveolin 1; Cholesterol; Dioxin receptor; Endocytosis; Membrane microdomains

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; CAVEOLIN 1; CHOLESTEROL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CAVEOLA; CELL MIGRATION; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENDOCYTOSIS; FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING; GENE SILENCING; IMMORTALIZED CELL LINE; IMMUNOPRECIPITATION; LIPID ANALYSIS; MOUSE; NONHUMAN; NULL ALLELE; PHENOTYPE; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN LIPID INTERACTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; SKIN FIBROBLAST; TRANSCRIPTION REGULATION; UPREGULATION; WILD TYPE; ANIMAL; CELL CULTURE; CELL MOTION; FIBROBLAST; GENETICS; KNOCKOUT MOUSE; METABOLISM; PHYSIOLOGY;

ANIMALS; CAVEOLIN 1; CELL MOVEMENT; CELLS, CULTURED; CHOLESTEROL; ENDOCYTOSIS; FIBROBLASTS; MICE; MICE, KNOCKOUT; RECEPTORS, ARYL HYDROCARBON;

EID: 84908211714     PISSN: None     EISSN: 1478811X     Source Type: Journal    
DOI: 10.1186/s12964-014-0057-7     Document Type: Article

References (58)

1. Nebert DW, Dalton TP, Okey AB, Gonzalez FJ: Role of aryl hydrocarbon receptor-mediated induction of the CYP1 enzymes in environmental toxicity and cancer. J Biol Chem 2004, 279:23847-23850.
2. Shimizu Y, Nakatsuru Y, Ichinose M, Takahashi Y, Kume H, Mimura J, Fujii-Kuriyama Y, Ishikawa T: Benzo[a]pyrene carcinogenicity is lost in mice lacking the aryl hydrocarbon receptor. Proc Natl Acad Sci U S A 2000, 97:779-782.
3. Pohjanvirta R: The AH receptor in Biology and Toxicology. New York: John Wiley & Sons; 2012.
4. Sauzeau V, Carvajal-Gonzalez JM, Riolobos AS, Sevilla MA, Menacho-Marquez M, Roman AC, Abad A, Montero MJ, Fernandez-Salguero P, Bustelo XR: Transcriptional factor aryl hydrocarbon receptor (Ahr) controls cardiovascular and respiratory functions by regulating the expression of the Vav3 proto-oncogene. J Biol Chem 2011, 286:2896-2909.
5. Cho YC, Zheng W, Jefcoate CR: Disruption of cell-cell contact maximally but transiently activates AhR-mediated transcription in 10T1/2 fibroblasts. Toxicol Appl Pharmacol 2004, 199:220-238.
6. Sadek CM, Allen-Hoffmann BL: Cytochrome P450IA1 is rapidly induced in normal human keratinocytes in the absence of xenobiotics. J Biol Chem 1994, 269:16067-16074.
7. Qin H, Powell-Coffman JA: The Caenorhabditis elegans aryl hydrocarbon receptor, AHR-1, regulates neuronal development. Dev Biol 2004, 270:64-75.
8. Barouki R, Coumoul X, Fernandez-Salguero PM: The aryl hydrocarbon receptor, more than a xenobiotic-interacting protein. FEBS Lett 2007, 581:3608-3615.
9. Gomez-Duran A, Carvajal-Gonzalez JM, Mulero-Navarro S, Santiago-Josefat B, Puga A, Fernandez-Salguero PM: Fitting a xenobiotic receptor into cell homeostasis: how the dioxin receptor interacts with TGFbeta signaling. Biochem Pharmacol 2009, 77:700-712.
10. Mulero-Navarro S, Pozo-Guisado E, Perez-Mancera PA, Alvarez-Barrientos A, Catalina-Fernandez I, Hernandez-Nieto E, Saenz-Santamaria J, Martinez N, Rojas JM, Sanchez-Garcia I, Fernandez-Salguero PM: Immortalized mouse mammary fibroblasts lacking dioxin receptor have impaired tumorigenicity in a subcutaneous mouse xenograft model. J Biol Chem 2005, 280:28731-28741.
11. Roman AC, Carvajal-Gonzalez JM, Rico-Leo EM, Fernandez-Salguero PM: Dioxin receptor deficiency impairs angiogenesis by a mechanism involving VEGF-A depletion in the endothelium and transforming growth factor-beta overexpression in the stroma. J Biol Chem 2009, 284:25135-25148.
12. Tomkiewicz C, Herry L, Bui LC, Metayer C, Bourdeloux M, Barouki R, Coumoul X: The aryl hydrocarbon receptor regulates focal adhesion sites through a non-genomic FAK/Src pathway. Oncogene 2013, 32:1811-1820.
13. Diry M, Tomkiewicz C, Koehle C, Coumoul X, Bock KW, Barouki R, Transy C: Activation of the dioxin/aryl hydrocarbon receptor (AhR) modulates cell plasticity through a JNK-dependent mechanism. Oncogene 2006, 25:5570-5574.
14. Carvajal-Gonzalez JM, Roman AC, Cerezo-Guisado MI, Rico-Leo EM, Martin-Partido G, Fernandez-Salguero PM: Loss of dioxin-receptor expression accelerates wound healing in vivo by a mechanism involving TGF{beta}. J Cell Sci 2009, 122: 1823-1833.
15. Carvajal-Gonzalez JM, Mulero-Navarro S, Roman AC, Sauzeau V, Merino JM, Bustelo XR, Fernandez-Salguero PM: The dioxin receptor regulates the constitutive expression of the vav3 proto-oncogene and modulates cell shape and adhesion. Mol Biol Cell 2009, 20:1715-1727.
16. Rey-Barroso J, Colo GP, Alvarez-Barrientos A, Redondo-Munoz J, Carvajal-Gonzalez JM, Mulero-Navarro S, Garcia-Pardo A, Teixido J, Fernandez-Salguero PM: The dioxin receptor controls beta1 integrin activation in fibroblasts through a Cbp-Csk-Src pathway. Cell Signal 2013, 25: 848-859.
17. Fra AM, Williamson E, Simons K, Parton RG: De novo formation of caveolae in lymphocytes by expression of VIP21-caveolin. Proc Natl Acad Sci U S A 1995, 92:8655-8659.
18. Parton RG, Hanzal-Bayer M, Hancock JF: Biogenesis of caveolae: a structural model for caveolin-induced domain formation. J Cell Sci 2006, 119:787-796.
19. Rothberg KG, Heuser JE, Donzell WC, Ying YS, Glenney JR, Anderson RG: Caveolin, a protein component of caveolae membrane coats. Cell 1992, 68:673-682.
20. Le Lay S, Kurzchalia TV: Getting rid of caveolins: phenotypes of caveolin-deficient animals. Biochim Biophys Acta 2005, 1746:322-333.
21. Patani N, Martin LA, Reis-Filho JS, Dowsett M: The role of caveolin-1 in human breast cancer. Breast Cancer Res Treat 2012, 131:1-15.
22. Tanase CP: Caveolin-1: a marker for pancreatic cancer diagnosis. Expert Rev Mol Diagn 2008, 8:395-404.
23. Grande-Garcia A, Echarri A, de Rooij J, Alderson NB, Waterman-Storer CM, Valdivielso JM, del Pozo MA: Caveolin-1 regulates cell polarization and directional migration through Src kinase and Rho GTPases. J Cell Biol 2007, 177:683-694.
24. Hill MM, Daud NH, Aung CS, Loo D, Martin S, Murphy S, Black DM, Barry R, Simpson F, Liu L, Pilch PF, Hancock JF, Parat MO, Parton RG: Co-regulation of cell polarization and migration by caveolar proteins PTRF/Cavin-1 and caveolin-1. PLoS One 2012, 7:e43041.
25. Parat MO, Anand-Apte B, Fox PL: Differential caveolin-1 polarization in endothelial cells during migration in two and three dimensions. Mol Biol Cell 2003, 14:3156-3168.
26. Beardsley A, Fang K, Mertz H, Castranova V, Friend S, Liu J: Loss of caveolin-1 polarity impedes endothelial cell polarization and directional movement. J Biol Chem 2005, 280:3541-3547.
27. van Deurs B, Roepstorff K, Hommelgaard AM, Sandvig K: Caveolae: anchored, multifunctional platforms in the lipid ocean. Trends Cell Biol 2003, 13:92-100.
28. Lim EJ, Majkova Z, Xu S, Bachas L, Arzuaga X, Smart E, Tseng MT, Toborek M, Hennig B: Coplanar polychlorinated biphenyl-induced CYP1A1 is regulated through caveolae signaling in vascular endothelial cells. Chem Biol Interact 2008, 176:71-78.
29. Majkova Z, Smart E, Toborek M, Hennig B: Up-regulation of endothelial monocyte chemoattractant protein-1 by coplanar PCB77 is caveolin-1-dependent. Toxicol Appl Pharmacol 2009, 237:1-7.
30. Grande-Garcia A, del Pozo MA: Caveolin-1 in cell polarization and directional migration. Eur J Cell Biol 2008, 87:641-647.
31. Ikuta T, Kobayashi Y, Kawajiri K: Cell density regulates intracellular localization of aryl hydrocarbon receptor. J Biol Chem 2004, 279:19209-19216.
32. Mayoral R, Fernandez-Martinez A, Roy R, Bosca L, Martin-Sanz P: Dispensability and dynamics of caveolin-1 during liver regeneration and in isolated hepatic cells. Hepatology 2007, 46:813-822.
33. Rizzo V, Morton C, DePaola N, Schnitzer JE, Davies PF: Recruitment of endothelial caveolae into mechanotransduction pathways by flow conditioning in vitro. Am J Physiol Heart Circ Physiol 2003, 285:H1720-1729.
34. Lajoie P, Nabi IR: Lipid rafts, caveolae, and their endocytosis. Int Rev Cell Mol Biol 2010, 282:135-163.
35. Bastiani M, Parton RG: Caveolae at a glance. J Cell Sci 2010, 123:3831-3836.
36. Pol A, Martin S, FernandezMA, Ingelmo-Torres M, Ferguson C, Enrich C, Parton RG: Cholesterol and fatty acids regulate dynamic caveolin trafficking through the Golgi complex and between the cell surface and lipid bodies. Mol Biol Cell 2005, 16:2091-2105.
37. Tanos R, Patel RD, Murray IA, Smith PB, Patterson AD, Perdew GH: Aryl hydrocarbon receptor regulates the cholesterol biosynthetic pathway in a dioxin response element-independent manner. Hepatology 2012, 55:1994-2004.
38. Simons K, Ikonen E: Functional rafts in cell membranes. Nature 1997, 387:569-572.
39. Castanho MA, Brown W, Prieto MJ: Filipin and its interaction with cholesterol in aqueous media studied using static and dynamic light scattering. Biopolymers 1994, 34:447-456.
40. Muller G, Hanekop N, Wied S, Frick W: Cholesterol depletion blocks redistribution of lipid raft components and insulin-mimetic signaling by glimepiride and phosphoinositolglycans in rat adipocytes. Mol Med 2002, 8:120-136.
41. Atger VM, de la Llera MM, Stoudt GW, Rodrigueza WV, Phillips MC, Rothblat GH: Cyclodextrins as catalysts for the removal of cholesterol from macrophage foam cells. J Clin Invest 1997, 99:773-780.
42. Martin S, Parton RG: Caveolin, cholesterol, and lipid bodies. Semin Cell Dev Biol 2005, 16:163-174.
43. Razani B, Engelman JA, Wang XB, Schubert W, Zhang XL, Marks CB, Macaluso F, Russell RG, Li M, Pestell RG, Di Vizio D, Hou H Jr, Kneitz B, Lagaud G, Christ GJ, Edelmann W, Lisanti MP: Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities. J Biol Chem 2001, 276:38121-38138.
44. Schubert W, Frank PG, Razani B, Park DS, Chow CW, Lisanti MP: Caveolae-deficient endothelial cells show defects in the uptake and transport of albumin in vivo. J Biol Chem 2001, 276:48619-48622.
45. Sharma DK, Brown JC, Choudhury A, Peterson TE, Holicky E, Marks DL, Simari R, Parton RG, Pagano RE: Selective stimulation of caveolar endocytosis by glycosphingolipids and cholesterol. Mol Biol Cell 2004, 15:3114-3122.
46. Dong B, Cheng W, Li W, Zheng J, Wu D, Matsumura F, Vogel CF: FRET analysis of protein tyrosine kinase c-Src activation mediated via aryl hydrocarbon receptor. Biochim Biophys Acta 1810, 2011:427-431.
47. Echarri A, Del Pozo MA: Caveolae internalization regulates integrin-dependent signaling pathways. Cell Cycle 2006, 5:2179-2182.
48. Allen JA, Yu JZ, Donati RJ, Rasenick MM: Beta-adrenergic receptor stimulation promotes G alpha s internalization through lipid rafts: a study in living cells. Mol Pharmacol 2005, 67:1493-1504.
49. Bastiaanse EM, Hold KM, Van der Laarse A: The effect of membrane cholesterol content on ion transport processes in plasma membranes. Cardiovasc Res 1997, 33:272-283.
50. Nguyen DH, Espinoza JC, Taub DD: Cellular cholesterol enrichment impairs T cell activation and chemotaxis. Mech Ageing Dev 2004, 125:641-650.
51. Fernandez-Salguero P, Pineau T, Hilbert DM, McPhail T, Lee SS, Kimura S, Nebert DW, Rudikoff S, Ward JM, Gonzalez FJ: Immune system impairment and hepatic fibrosis in mice lacking the dioxin-binding Ah receptor. Science 1995, 268:722-726.
52. Rico-Leo EM, Alvarez-Barrientos A, Fernandez-Salguero PM: Dioxin Receptor Expression Inhibits Basal and Transforming Growth Factor beta-induced Epithelial-to-mesenchymal Transition. J Biol Chem 2013, 288:7841-7856.
53. Santiago-Josefat B, Pozo-Guisado E, Mulero-Navarro S, Fernandez-Salguero PM: Proteasome inhibition induces nuclear translocation and transcriptional activation of the dioxin receptor in mouse embryo primary fibroblasts in the absence of xenobiotics. Mol Cell Biol 2001, 21:1700-1709.
54. Pozo-Guisado E, Lorenzo-Benayas MJ, Fernandez-Salguero PM: Resveratrol modulates the phosphoinositide 3-kinase pathway through an estrogen receptor alpha-dependent mechanism: relevance in cell proliferation. Int J Cancer 2004, 109:167-173.
55. Santiago-Josefat B, Fernandez-Salguero PM: Proteasome inhibition induces nuclear translocation of the dioxin receptor through an Sp1 and protein kinase C-dependent pathway. J Mol Biol 2003, 333:249-260.
56. Roman AC, Benitez DA, Carvajal-Gonzalez JM, Fernandez-Salguero PM: Genome-wide B1 retrotransposon binds the transcription factors dioxin receptor and Slug and regulates gene expression in vivo. Proc Natl Acad Sci U S A 2008, 105:1632-1637.
57. Christian AE, Haynes MP, Phillips MC, Rothblat GH: Use of cyclodextrins for manipulating cellular cholesterol content. J Lipid Res 1997, 38:2264-2272.
58. Yumoto R, Suzuka S, Oda K, Nagai J, Takano M: Endocytic uptake of FITC-albumin by human alveolar epithelial cell line A549. Drug Metab Pharmacokinet 2012, 27:336-343.